![Jack Khattar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Khattar
Gründer bei
SUPERNUS PHARMACEUTICALS, INC.
Vermögen: 102 Mio $ am 31.05.2026
Profil
Jack A. Khattar is the founder of Supernus Pharmaceuticals, Inc., founded in 2005, where the titles held are President, CEO, Secretary & Director.
Current jobs include Chairman at Cognition Therapeutics, Inc. since 2021, President, Secretary, Treasurer & Director at Adamas Pharmaceuticals LLC since 2021, President, Treasurer & Director at SAGE Therapeutics, Inc. starting in 2025, and Advisor at New Rhein Healthcare Investors.
Former jobs include President, Chief Executive Officer & Director at Shire Laboratories, Inc. from 1999 to 2005, Chairman at scPharmaceuticals, Inc. from 2017 to 2025, Director at Prevacus, Inc. from 2015 to 2020, Director at Navitor Pharmaceuticals, Inc., Director at Rockville Economic Development, Inc. from 2003 to 2013, Principal at Merck & Co., Inc., Principal at Novartis Corp., Principal at Kodak Ltd., Member at Licensing Executives Society, Executive Officer at CIMA Labs, Inc., and Member at Shire Plc from 1999 to 2004.
Education includes undergraduate studies at American University of Beirut and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.04.2026 | 2.199.244 ( 3,92 % ) | 102 Mio $ | 31.05.2026 | |
| 17.06.2026 | 73.500 ( 0,08 % ) | 86 730 $ | 31.05.2026 |
Aktive Positionen von Jack Khattar
| Unternehmen | Position | Beginn |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Gründer | 30.03.2005 |
| COGNITION THERAPEUTICS, INC. | Vorsitzender | 20.04.2021 |
| ADAMAS PHARMACEUTICALS, INC. | Präsident | 24.11.2021 |
| SAGE THERAPEUTICS, INC. | Präsident | 31.07.2025 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Berater | - |
Ehemalige bekannte Positionen von Jack Khattar
| Unternehmen | Position | Ende |
|---|---|---|
| SCPHARMACEUTICALS INC. | Vorsitzender | 07.10.2025 |
Prevacus, Inc.
 Prevacus, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of mild traumatic brain injuries | Direktor/Vorstandsmitglied | 01.01.2020 |
Rockville Economic Development, Inc.
 Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support for industries in the technological area and a developer for new industries | Direktor/Vorstandsmitglied | 01.01.2013 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Vorstandsvorsitzender | 01.01.2005 |
| ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jack Khattar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Prevacus, Inc.
Prevacus, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of mild traumatic brain injuries | Health Technology |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
Kodak Ltd.
 Kodak Ltd. Electronics/AppliancesConsumer Durables Develops photographic, synthetic chemicals and photographic films | Consumer Durables |
American University of Beirut
 American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Commercial Services |
Licensing Executives Society
 Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Commercial Services |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Rockville Economic Development, Inc.
Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support for industries in the technological area and a developer for new industries | Commercial Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
